IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway by Bainbridge, A, Walker, S, Smith, J, Patterson, K, Dutt, A, Ng, YM, Thomas, HD, Wilson, L, McCullough, B, Jones, D, Maan, A, Banks, P, McCracken, SR, Gaughan, L, Robson, CN, Coffey, K

Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy by Willoughby, CE, Jiang, Y, Thomas, HD, Willmore, E, Kyle, S, Wittner, A, Phillips, N, Zhao, Y, Tudhope, SJ, Prendergast, L, Junge, G, Lourenco, LM, Finlay, MRV, Turner, P, Munck, JM, Griffin, RJ, Rennison, T, Pickles, J, Cano, C, Newell, DR, Reeves, HL, Ryan, AJ, Wedge, SR